These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 7775839)
21. [Significance of COX-2, p53, proliferating cell nuclear antigen and nm23 expressions in gastric cancer and its behavior]. Ji SQ; Hua YW; Zhuang J; Gao Y; Kong Y; Han SL; Shao YF Ai Zheng; 2002 Jun; 21(6):619-24. PubMed ID: 12452062 [TBL] [Abstract][Full Text] [Related]
22. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas. Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745 [TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium. Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611 [TBL] [Abstract][Full Text] [Related]
24. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma. Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009 [TBL] [Abstract][Full Text] [Related]
25. [Helicobacter pylori infection and expression of PCNA, p53, c-erbB-2 in carcinoma and precancerours lesions of the stomach]. Lu W; Chen L; Gong H Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):125-7. PubMed ID: 11776853 [TBL] [Abstract][Full Text] [Related]
26. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression. Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717 [TBL] [Abstract][Full Text] [Related]
27. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases. Lewis JE; Olsen KD; Sebo TJ Hum Pathol; 2001 Jun; 32(6):596-604. PubMed ID: 11431714 [TBL] [Abstract][Full Text] [Related]
28. [Immunohistochemical study of p53, c-erbB-2 and nm23 proteins in human gastric cancer]. Wei Z; Wu Y; Zhai Z Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):378-81. PubMed ID: 10920922 [TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical detection of p53 protein, c-erbB-2 protein, epidermal growth factor receptor protein and proliferating cell nuclear antigen in gastric carcinoma. Jang WI; Yang WI; Lee CI; Kim HS; Song KS; Cho MY; Park JK; Shim YH J Korean Med Sci; 1993 Aug; 8(4):293-304. PubMed ID: 7911025 [TBL] [Abstract][Full Text] [Related]
30. Expression and prognostic significance of gastric-specific annexin A10 in diffuse- and intestinal-type gastric carcinoma. Lu SH; Chen YL; Shun CT; Lai JN; Peng SY; Lai PL; Hsu HC J Gastroenterol Hepatol; 2011 Jan; 26(1):90-7. PubMed ID: 21175800 [TBL] [Abstract][Full Text] [Related]
31. Relationship between p53 expression and gastric cancers in cardia and antrum. Azarhoush R; Keshtkar AA; Amiriani T; Kazemi-Nejad V Arch Iran Med; 2008 Sep; 11(5):502-6. PubMed ID: 18759514 [TBL] [Abstract][Full Text] [Related]
32. [New molecular prognostic markers in gastric carcinoma]. Yoshida K; Yasui W; Yokozaki H; Nishimoto N; Kagawa Y; Toge T; Tahara E; Yoshida T; Terada M Gan To Kagaku Ryoho; 1998 Nov; 25(13):2021-7. PubMed ID: 9838902 [TBL] [Abstract][Full Text] [Related]
33. Long-term follow-up study of patients with gastric adenomas with malignant transformation. An immunohistochemical and histochemical analysis. Kolodziejczyk P; Yao T; Oya M; Nakamura S; Utsunomiya T; Ishikawa T; Tsuneyoshi M Cancer; 1994 Dec; 74(11):2896-907. PubMed ID: 7954254 [TBL] [Abstract][Full Text] [Related]
35. Highly aggressive behavior and poor prognosis of small-cell carcinoma in the alimentary tract: flow-cytometric analysis and immunohistochemical staining for the p53 protein and proliferating cell nuclear antigen. Kimura H; Konishi K; Maeda K; Yabushita K; Tsuji M; Miwa A Dig Surg; 1999; 16(2):152-7. PubMed ID: 10207243 [TBL] [Abstract][Full Text] [Related]
36. Many a mickle makes a muckle. Translating a gastric cancer phenotype into a bigger thing. Blum MA; Ajani JA Onkologie; 2011; 34(10):499-500. PubMed ID: 21985847 [No Abstract] [Full Text] [Related]
37. Clinicopathological significance of c-erbB-2 protein expression in human gastric carcinoma. Tateishi M; Toda T; Minamisono Y; Nagasaki S J Surg Oncol; 1992 Apr; 49(4):209-12. PubMed ID: 1348293 [TBL] [Abstract][Full Text] [Related]
38. [Immunohistochemical study of growth factors and oncogenes in gastric carcinomas]. Yamagiwa H; Onishi N; Onishi T; Onishi T; Onishi H; Satomoto K; Watanabe K; Nishii M Rinsho Byori; 1993 Jul; 41(7):795-9. PubMed ID: 8103127 [TBL] [Abstract][Full Text] [Related]
39. Diagnostic Usefulness of p53 Immunostaining in Gastric Cancer and Dysplasia: A Real-world Clinical Experience. Park JH; Seo AN; Kim M In Vivo; 2024; 38(4):1865-1874. PubMed ID: 38936896 [TBL] [Abstract][Full Text] [Related]
40. Cell proliferation patterns and p53 expression in gastric dysplasia. Miracco C; Spina D; Vindigni C; Filipe MI; Tosi P Int J Cancer; 1995 Jul; 62(2):149-54. PubMed ID: 7622288 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]